ProVise Management Group LLC Invests $810,000 in Iqvia Holdings Inc (IQV) Stock

ProVise Management Group LLC bought a new stake in Iqvia Holdings Inc (NYSE:IQV) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,277 shares of the medical research company’s stock, valued at approximately $810,000.

Other large investors also recently added to or reduced their stakes in the company. Franklin Street Advisors Inc. NC acquired a new position in Iqvia in the fourth quarter valued at about $7,446,000. Chevy Chase Trust Holdings Inc. acquired a new position in Iqvia in the fourth quarter valued at about $14,462,000. Icon Advisers Inc. Co. acquired a new position in Iqvia in the fourth quarter valued at about $852,000. Bremer Trust National Association acquired a new position in Iqvia in the fourth quarter valued at about $1,445,000. Finally, Nisa Investment Advisors LLC acquired a new position in Iqvia in the fourth quarter valued at about $920,000. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Iqvia Holdings Inc (NYSE:IQV) opened at $100.06 on Wednesday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.29. The stock has a market capitalization of $20,513.85, a PE ratio of 22.52, a P/E/G ratio of 1.34 and a beta of 0.61. Iqvia Holdings Inc has a fifty-two week low of $75.94 and a fifty-two week high of $110.67.

A number of equities research analysts have recently commented on the company. Mizuho set a $97.00 price target on Iqvia and gave the stock a “hold” rating in a research report on Wednesday, January 24th. SunTrust Banks reaffirmed a “hold” rating and set a $110.00 price target on shares of Iqvia in a research report on Monday, January 22nd. Zacks Investment Research lowered Iqvia from a “buy” rating to a “hold” rating in a research report on Friday, January 19th. Evercore ISI assumed coverage on Iqvia in a research report on Thursday, January 18th. They set an “outperform” rating and a $112.00 price target on the stock. Finally, Mitsubishi UFJ Financial Group assumed coverage on Iqvia in a research report on Friday, December 15th. They set a “neutral” rating and a $112.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $109.71.

In other Iqvia news, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total value of $764,776,314.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John Connaughton sold 1,163,191 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total value of $118,645,482.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,727,078 shares of company stock valued at $890,124,079. 6.40% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “ProVise Management Group LLC Invests $810,000 in Iqvia Holdings Inc (IQV) Stock” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/14/provise-management-group-llc-invests-810000-in-iqvia-holdings-inc-iqv-stock.html.

Iqvia Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).

Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply